Trial Profile
An Observational, Prospective, Open label study comparing enteric-coated mycophenolate sodium (EC-MPS) with Mycophenolate mofetil (MMF) with calcineurin inhibitor (CNI) de-novo in patients after primary liver transplant.
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 31 Aug 2016
Price :
$35
*
At a glance
- Drugs Mycophenolate mofetil (Primary) ; Mycophenolate sodium (Primary)
- Indications Liver transplant rejection
- Focus Adverse reactions
- 01 Oct 2013 New trial record